<DOC>
	<DOC>NCT01025973</DOC>
	<brief_summary>The investigators will perform biochemical and metabolic evaluations on cord blood, venous blood of the mother and urine of the foetus and mother using time-of-flight and tandem mass spectrometry. The investigators could evaluate, dose and validate gestational diabetes mellitus biomarkers of the fetus and mother.</brief_summary>
	<brief_title>Evaluation and Validation of New Biomarkers by Mass Spectrometry</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>For women: Aged 18 or more 24 weeks of gestation or more Type 1, type 2 or gestational diabetes mellitus for group 1 Without diabetes for group 2. For newborn: 37 weeks of gestation or more Birth weight 2500 g or more Multiple birth</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>